As we move forward with clinical research for our anti-aging glycopeptide, AAGP®, we continue to uncover new areas of opportunity for the molecule. See how AAGP® is helping to provide more hope for patients and investors in the areas of ophthalmology, transplants, dermatology and biomanufacturing.
byprotokinetixp
Benefits of AAGP® | biotechnology investments | Type 1 Diabetes
byprotokinetixp
AAGP® | biotechnology | biotechnology investments | dry-eye | market opportunity
Talk to a member of the ProtoKinetix team to learn more about our research and results.
ProtoKinetix, Inc.
109 W Main St.
Dalton, OH 44618, USA
TEL: (330) 445-4971
ProtoKinetix, Inc.
412 Mulberry St
Marietta, OH 45750, USA
TEL: (740) 434-5041